Drug Research
GHIT Fund Invests ¥790M On Neglected Tropical Disease Items
Two neglected tropical illnesses, lymphatic filariasis and onchocerciasis, will receive a combined investment of about 790-million-yen ($5.3 million) from the Global Health Innovative Technology (GHIT)...
Drug Research
Pharma-Expansion In Africa Necessitates Homegrown Investment
The growth of the domestic pharmaceutical industry and a reduction in reliance on imports might be facilitated by funding AI-based research and development and focusing...
Drug Research
The EMA Endorses Controls On Immune-Regulating Medicines
Due to safety concerns, advisors to the European Medicines Agency on November 11th suggested restricting the use of a class of frequently prescribed anti-inflammatory medications....
Drug Research
Australia Allows Faecal Transplants To Restore Gut Health
Australia is the first country in the world to have awarded regulatory approval for faeces transplants.
The healthy genetic material for this donation comes from the...
Drug Research
Legal, Compliance Collab Between ProductLife And EIT Health
ProductLife Group (PLG), a supplier of regulation and compliance solutions for the life sciences sector, has joined the Venture Centre of Excellence, EIT Health's regulatory...
Drug Research
NHS Permits Potentially Life-Saving Breast Cancer Medicine
The confidential agreement reached by the NHS and the manufacturer is expected to assist up to 1,600 women annually who have high-risk, triple-negative breast cancer....
Drug Research
$2mn In The US, Gene Therapies Might Become The...
In recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised medicines. Most notably, bluebird Bio...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.